Emerald Advisers’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,829
| Closed | -$45K | – | 345 |
|
|
2019
Q3 | $45K | Hold |
1,829
| – | – | ﹤0.01% | 243 |
|
|
2019
Q2 | $65K | Sell |
1,829
-2,631
| -59% | -$93.5K | ﹤0.01% | 247 |
|
|
2019
Q1 | $200K | Hold |
4,460
| – | – | 0.01% | 242 |
|
|
2018
Q4 | $214K | Sell |
4,460
-1,550
| -26% | -$74.4K | 0.01% | 234 |
|
|
2018
Q3 | $401K | Buy |
6,010
+1,173
| +24% | +$78.3K | 0.01% | 218 |
|
|
2018
Q2 | $228K | Buy |
+4,837
| New | +$228K | 0.01% | 238 |
|
|
2017
Q4 | – | Sell |
-1,694
| Closed | -$129K | – | 253 |
|
|
2017
Q3 | $129K | Buy |
1,694
+774
| +84% | +$58.9K | 0.01% | 233 |
|
|
2017
Q2 | $87K | Hold |
920
| – | – | ﹤0.01% | 221 |
|
|
2017
Q1 | $73K | Sell |
920
-8
| -0.9% | -$635 | ﹤0.01% | 231 |
|
|
2016
Q4 | $77K | Sell |
928
-16,050
| -95% | -$1.33M | ﹤0.01% | 264 |
|
|
2016
Q3 | $1.9M | Buy |
16,978
+4,062
| +31% | +$454K | 0.08% | 206 |
|
|
2016
Q2 | $1.43M | Sell |
12,916
-546
| -4% | -$60.5K | 0.07% | 219 |
|
|
2016
Q1 | $1.41M | Sell |
13,462
-21,425
| -61% | -$2.24M | 0.07% | 226 |
|
|
2015
Q4 | $2.81M | Hold |
34,887
| – | – | 0.13% | 176 |
|
|
2015
Q3 | $2.42M | Buy |
34,887
+10,846
| +45% | +$752K | 0.13% | 190 |
|
|
2015
Q2 | $2.35M | Buy |
24,041
+16,541
| +221% | +$1.62M | 0.11% | 199 |
|
|
2015
Q1 | $874K | Buy |
7,500
+262
| +4% | +$30.5K | 0.04% | 258 |
|
|
2014
Q4 | $797K | Sell |
7,238
-458
| -6% | -$50.4K | 0.04% | 255 |
|
|
2014
Q3 | $910K | Buy |
7,696
+20
| +0.3% | +$2.37K | 0.05% | 253 |
|
|
2014
Q2 | $996K | Sell |
7,676
-7,599
| -50% | -$986K | 0.06% | 253 |
|
|
2014
Q1 | $2.44M | Buy |
+15,275
| New | +$2.44M | 0.14% | 181 |
|